Misleading measures in Vitamin D analysis: A novel LC-MS/MS assay to account for epimers and isobars

Nutrition Journal

Volumn 10, Issue 1, 2011, Pages

  Shah, Iltaf ^a   James, Ricky ^a   Barker, James ^a   Petroczi, Andrea ^a   Naughton, Declan P ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYERGOCALCIFEROL; 7 ALPHA HYDROXY 4 CHOLESTEN 3 ONE; ALFACALCIDOL; CALCIFEDIOL; COLECALCIFEROL; STANOZOLOL; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN;

ACCURACY; ADULT; ARTICLE; BLOOD SAMPLING; CAUCASIAN; CHIRALITY; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ELUTION; EPIMER; FILTER; HUMAN; ISOBAR; ISOMERISM; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; MULTIPLE REACTION MONITORING; NORMAL HUMAN; REACTOR MONITORING; SOLID PHASE EXTRACTION; STANDARD; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM; BLOOD; IMMUNOASSAY; METHODOLOGY; TANDEM MASS SPECTROMETRY;

25-HYDROXYVITAMIN D 2; ADULT; CALCIFEDIOL; CHROMATOGRAPHY, LIQUID; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; IMMUNOASSAY; MALE; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VITAMINS; YOUNG ADULT;

EID: 79959214925     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-10-46     Document Type: Article

References (51)

1. Vitamin D. AS Dusso AJ Brown E Slatopolsky, Am J Physiol Renal Physiol 2005 289 8 F28 10.1152/ajprenal.00336.2004 15951480
2. Vitamin D deficiency. MF Holick, New Engl J Med 2007 357 266 281 10.1056/NEJMra070553 17634462
3. Solar ultraviolet radiation and Vitamin D: a historical perspective. K Rajakumar SL Greenspan SB Thomas FM Holick, Am J Public Health 2007 97 1746 1754 10.2105/AJPH.2006.091736 17761571 (Pubitemid 351182279)
4. Sunlight and Vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. MF Holick, Am J Clin Nutr 2004 80 6 Suppl 1678S 1688S 15585788
5. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. ML Melamed P Muntner ED Michos J Uribarri C Weber J Sharma P Raggi, Arterioscler Thromb Vasc Biol 2008 28 6 1179 1185 10.1161/ATVBAHA.108.165886 18417640
6. Vitamin D status: measurement, interpretation, and clinical application. MF Holick, Ann Epidemiol 2009 19 73 78 10.1016/j.annepidem.2007.12.001 18329892
7. Vitamin D in health and disease: Current perspectives. R Zhang DP Naughton, Nutr J 2010 9 65 10.1186/1475-2891-9-65 21143872
8. Circulating 25-hydroxyvitamin D levels indicative of Vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. BW Hollis, J Nutr 2005 135 317 322 15671234 (Pubitemid 40194499)
9. Intestinal cholecalciferol absorption in the elderly and in younger adults. JM Barragry MW France D Corless SP Gupta S Switala BJ Boucher RD Cohen, Clin Sci Mol Med 1978 55 213 220 209929 (Pubitemid 8386869)
10. Metabolism of intravenously administered cholecalciferol in man. JM Barragry MW France BJ Boucher RD Cohen, Clin Endocrinol(Oxf) 1979 11 491 495 10.1111/j.1365-2265.1979.tb03101.x (Pubitemid 10175105)
11. Serum Vitamin D2 and Vitamin D3 metabolite concentrations and absorption of Vitamin D2 in elderly subjects. TL Clemens XY Zhou M Myles D Endres R Lindsay, J Clin Endocrinol Metab 1986 63 656 660 10.1210/jcem-63-3-656 3488327 (Pubitemid 16050566)
12. The measurement of Vitamin D: analytical aspects. JE Zerwekh, Ann Clin Biochem 2004 41 272 281 10.1258/0004563041201464 15298739 (Pubitemid 38954876)
13. Gas chromatography and high-performance liquid chromatography of natural steroids. K Shimada K Mitamura T Higashi, J Chromatogr A 2001 935 141 172 10.1016/S0021-9673(01)00943-8 11762773 (Pubitemid 33044645)
14. Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation. GD Carter CR Carter E Gunter J Jones G Jones HL Makin S Sufi, J Steroid Biochem Mol Biol 2004 89-90 467 471 15225822 (Pubitemid 38844332)
15. The determination of circulating 25-hydroxyvitamin D: no easy task. BW Hollis, J Clin Endocrinol Metab 2004 89 3149 3151 10.1210/jc.2004-0682 15240585 (Pubitemid 38951876)
16. A sensitive competitive protein-binding assay for Vitamin D in plasma. RL Horst TA Reinhardt DC Beitz ET Littledike, Steroids 1981 37 581 591 10.1016/S0039-128X(81)90403-7 6266082 (Pubitemid 11090420)
17. Assay of Vitamins D2 and D3, and 25-hydroxyvitamins D2 and D3 in human plasma by high-performance liquid chromatography. G Jones, Clin Chem 1978 24 287 298 203413 (Pubitemid 8293929)
18. Measurement of 25-hydroxyvitamin D by the Nichols ADVANTAGE, DiaSorin LIAISON, DiaSorin RIA, and liquid chromatography-tandem mass spectrometry. AH Terry T Sandrock AW Meikle, Clin Chem 2005 51 1565 1566 10.1373/clinchem.2005. 054239 16040866 (Pubitemid 41060911)
19. How accurate are assays for 25-hydroxyvitamin D? Data from the international Vitamin D external quality assessment scheme. GD Carter R Carter J Jones J Berry, Clin Chem 2004 50 2195 2197 10.1373/clinchem.2004.040683 15375018 (Pubitemid 39425873)
20. Correlation among 25-hydroxyvitamin D assays. N Binkley D Krueger D Gemar MK Drezner, J Clin Endocrinol Metab 2008 93 1804 1808 10.1210/jc.2007-2340 18319318
21. Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization. N Binkley D Krueger CS Cowgill L Plum E Lake KE Hansen HF Deluca MK Drezner, J Clin Endocrinol Metab 2004 89 3152 3157 10.1210/jc.2003-031979 15240586 (Pubitemid 38951877)
22. Serum 25-hydroxyvitamin D measurement in a large population survey with statistical harmonization of assay variation to an international standard. E Hyppönen S Turner P Cumberland C Power I Gibb, J Clin Endocrinol Metab 2007 92 4615 4622 10.1210/jc.2007-1279 17726070 (Pubitemid 350223435)
23. Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference. HJ Roth H Schmidt-Gayk H Weber C Niedrau, Ann Clin Biochem 2008 45 153 159 10.1258/acb.2007.007091 18325178 (Pubitemid 351724586)
24. Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of Vitamin D deficiency. AK Saenger TJ Laha DE Bremner SM Sadrzadeh, Am J Clin Pathol 2006 125 914 920 10.1309/J32UF7GTQPWN25AP 16690491 (Pubitemid 43801542)
25. Identification and determination of fat-soluble Vitamins and metabolites in human serum by liquid chromatography/triple quadrupole mass spectrometry with multiple reaction monitoring. F Priego Capote J Ruiz Jimenez JM Mata Granados MD Luque de Castro, Rapid Commun Mass Spectrom 2007 21 1745 1754 10.1002/rcm.3014 17486676
26. Low Vitamin D status: definition, prevalence, consequences, and correction. N Binkley R Ramamurthy D Krueger, Endocrinol Metab Clin North Am 2010 39 287 301 10.1016/j.ecl.2010.02.008 20511052
27. Application of 4-(4-nitrophenyl)-1,2,4-triazoline-3, 5-dione to analysis of 25-hydroxyvitamin D3 in human plasma by liquid chromatography/electron capture atmospheric pressure chemical ionization-mass spectrometry. T Higashi A Yamauchi K Shimada, Anal Sci 2003 19 941 943 10.2116/analsci.19.941 12834240
28. Characterization of urinary metabolites of Vitamin D(3) in man under physiological conditions using liquid chromatography-tandem mass spectrometry. T Higashi S Homma H Iwata K Shimada, J Pharm Biomed Anal 2002 31 947 955 (Pubitemid 34692596)
29. Quantification of circulating 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry. M Vogeser, J Steroid Biochem Mol Biol 2010 121 565 573 10.1016/j.jsbmb.2010.02.025 20206693
30. 3. Z Maunsell DJ Wright SJ Rainbow, Clin Chem 2005 51 1683 1690 10.1373/clinchem.2005.052936 16020493 (Pubitemid 41233104)
31. Positive, site-specific associations between bone mineral status, fitness, and time spent at high-impact activities in 16- to 18-year-old boys. F Ginty KL Rennie L Mills S Stear S Jones A Prentice, Bone 2005 36 101 110 10.1016/j.bone.2004.10.001 15664008 (Pubitemid 40128280)
32. A sensitive LC/MS/MS assay of 25OH Vitamin D3 and 25OH Vitamin D2 in dried blood spots. D Eyles C Anderson P Ko A Jones A Tomas T Burne PB Mortensen B Norggard-Pederser DM Hougaard J McGrath, Clin Chim Acta 2009 403 145 151 10.1016/j.cca.2009.02.005 19232332
33. Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a Cookson-type reagent. T Higashi D Awada K Shimada, Biol Pharm Bull 2001 24 738 743 10.1248/bpb.24.738 11456110 (Pubitemid 32633478)
34. Determination of 24,25-dihydroxyvitamin D(3) in human plasma using liquid chromatography-mass spectrometry after derivatization with a Cookson-type reagent. T Higashi D Awada K Shimada, Biomed Chromatogr 2001 15 133 140 10.1002/bmc.43 11268053
35. Sensitivity enhancement in liquid chromatography/atmospheric pressure ionization mass spectrometry using derivatization and mobile phase additives. S Gao ZP Zhang HT Karnes, J Chromatogr B 2005 825 98 110 10.1016/j.jchromb.2005. 04.021 (Pubitemid 41423593)
36. Dual parallel mass spectrometry for lipid and Vitamin D analysis. WC Byrdwell, J Chromatogr A 2010 25 3992 4003
37. Measurement of 25-hydroxyvitamin D3 (25OHD3) and 25-hydroxyvitamin D2 (25OHD2) in human serum using liquid chromatography-tandem mass spectrometry and its comparison to a radioimmunoassay method. H Chen LF McCoy RL Schleicher CM Pfeiffer, Clin Chim Acta 2008 391 6 12 10.1016/j.cca.2008.01.017 18279671
38. Differentiation-related pathways of 1,25-dihydroxycholecalciferol metabolism in human colon adenocarcinoma-derived Caco-2 cells: production of 1,25-dihydroxy-3epi-cholecalciferol. MG Bischof ML Siu-Caldera A Weiskopf P Vouros HS Cross M Peterlik GS Reddy, Exp Cell Res 1998 241 194 201 10.1006/excr.1998.4044 9633528 (Pubitemid 28366594)
39. Production of 1,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed. ML Siu-Caldera H Sekimoto A Weiskopf P Vouros KR Muralidharan WH Okamura J Bishop AW Norman MR Uskokovic I Schuster GS Reddy, Bone 1999 24 457 463 10.1016/S8756-3282(99)00019-8 10321905 (Pubitemid 29234134)
40. 1,25-Dihydroxy-3-epi-vitamin D3: in vivo metabolite of 1,25-dihydroxyvitamin D3 in rats. H Sekimoto ML Siu-Caldera A Weiskopf P Vouros KR Muralidharan WH Okamura MR Uskokovic GS Reddy, FEBS Let 1999 448 278 282 10.1016/S0014-5793(99)00377-4 (Pubitemid 29168503)
41. C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of Vitamin D status. RJ Singh RL Taylor GS Reddy SKG Grebe, J Clin Endocrinol Metab 2006 91 3055 3061 10.1210/jc.2006-0710 16720650 (Pubitemid 44271755)
42. Cell specificity and properties of the C-3 epimerization of Vitamin D3 metabolites. M Kamao S Tatematsu N Sawada T Sakaki S Hatakeyama N Kubodera T Okano, J Steroid Biochem Mol Biol 2004 89-90 39 42 15225744 (Pubitemid 38844257)
43. C-3 epimerization of Vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1 or C-24 hydroxylation. M Kamao S Tatematsu S Hatakeyama T Sakaki N Sawada K Inouye K Ozono N Kubodera GS Reddy T Okano, J Biol Chem 2004 279 15897 15907 10.1074/jbc.M311473200 14757768 (Pubitemid 38509277)
44. 25-hydroxyvitamin D assays: the quest for accuracy. GD Carter, Clin Chem 2009 55 1300 1302 10.1373/clinchem.2009.125906 19423731
45. 3by liquid chromatography-tandem mass spectrometry. M Vogeser A Kyriatsoulis E Huber U Kobold, Clin Chem 2004 50 1145 1147
46. Serum 25-OH Vitamin D2 and D3 are stable under exaggerated conditions. JG Lewis PA Elder, Clin Chem 2008 54 1931 1932 10.1373/clinchem.2008.111526 18957567
47. Environmental factors that influence the cutaneous production of Vitamin D. MF Holick, Am J Clin Nutr 1995 61 3 Suppl 638S 645S 7879731
48. Joint position statement issued to provide vitamin D clarity. http://info.cancerresearchuk.org/news/archive/cancernews/2010-12-16-Joint- position-statement-issued-to-provide-vitamin-D-clarity-?rss=true
49. Vitamin D status: Measurement, interpretation, and clinical application. MF Holick, Ann Epidemiol 2009 19 2 73 78 10.1016/j.annepidem.2007.12.001 18329892
50. Dietary Supplement Fact Sheet: Vitamin D. http://ods.od.nih.gov/ factsheets/vitamind
51. Diagnosis and management of vitamin D deficiency. SHS Pearce TD Cheetham, BMJ 2010 340 5664 10.1136/bmj.b5664 20064851